UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

Annals of oncology, 2021-05, Vol.32 (5), p.631-641

2021

Volltextzugriff (PDF)

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Annals of oncology, 2019-04, Vol.30, p.ii77-ii77

2019

Volltextzugriff (PDF)

Thalidomide Radiosensitizes Tumors through Early Changes in the Tumor Microenvironment

Clinical cancer research, 2005-01, Vol.11 (2), p.743-750

2005

Volltextzugriff (PDF)

Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331

Annals of oncology, 2018-12, Vol.29, p.x43-x43

2018

Volltextzugriff (PDF)

68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743)

Annals of oncology, 2020-12, Vol.31, p.S1445-S1445

2020

Volltextzugriff (PDF)

PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers

European psychiatry, 2010, Vol.25 (S1), p.1455-1455, Article 25-E1438

2010

Volltextzugriff (PDF)

749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032

Annals of oncology, 2020-09, Vol.31, p.S582-S583

2020

Volltextzugriff (PDF)

ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.e42-e42

2020

Volltextzugriff (PDF)

A randomized, open-label, phase 3 study of nivolumab in combination with ipilimumab vs extreme regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as first-line therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-CheckMate 651

Annals of oncology, 2016-10, Vol.27, p.vi350-vi350

2016

Volltextzugriff (PDF)

LBA1_PRNivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Double-blind, two-arm, phase 2 study of nivolumab (nivo) in combination with ipilimumab (ipi) versus nivo and ipi-placebo (PBO) as first-line (1L) therapy in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)—CheckMate 714

Annals of oncology, 2016-10, Vol.27, p.vi350-vi350

2016

Volltextzugriff (PDF)

LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

Botulinum toxin potentiates cancer radiotherapy and chemotherapy

Clinical cancer research, 2006-02, Vol.12 (4), p.1276-1283

2006

Volltextzugriff (PDF)

Brivanib (B) in Advanced Ovarian Cancer (OC): Subset Results of a Phase 2 Randomized Discontinuation Trial (RDT)

Annals of oncology, 2012-09, Vol.23, p.ix319

2012

Volltextzugriff (PDF)

Optimal assessment of treatment benefit with targeted agents for hepatocellular carcinoma (HCC): An analysis of brivanib phase II data

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4096-4096

2010

Volltextzugriff (PDF)

Free Radicals in Licorice-Flavored Sweets Can Be Detected Noninvasively Using Low Frequency Electron Paramagnetic Resonance after Oral Administration to Mice

The Journal of nutrition, 2000-07, Vol.130 (7), p.1831-1833

2000

Volltextzugriff (PDF)

Epsilon iron as a spin-smectic state

Proceedings of the National Academy of Sciences - PNAS, 2019-10, Vol.116 (41), p.20280-20285

2019

Volltextzugriff (PDF)

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-07, Vol.373 (2), p.123-135

2015

Volltextzugriff (PDF)

Regard croisé sur les jardins partagés et les Urbane Gemeinschaftsgärten

Revue germanique internationale (Evry), 2023-11, p.225-239

Baudelet-Stelmacher, Laurence

2023

Volltextzugriff (PDF)

Laser-induced breakdown spectroscopy of copper with a 2 μm thulium fiber laser

Optics express, 2010-04, Vol.18 (8), p.7905

2010

Volltextzugriff (PDF)

Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-12, Vol.322 (22), p.2179

2019

Volltextzugriff (PDF)

Are Nutritional Guidelines Followed in the Pediatric Intensive Care Unit?

Frontiers in pediatrics, 2021-06, Vol.9, p.648867-648867

2021

Volltextzugriff (PDF)

Pollution et risque alimentaire dans les jardins partagés franciliens

Revue d'ethnoécologie, 2015-12

Baudelet, Laurence

2015

Volltextzugriff (PDF)

Les 20 printemps des jardins partagés français. Bilan et perspectives

In situ (Paris), 2018-12

Baudelet-Stelmacher, Laurence

2018

Volltextzugriff (PDF)

Dynamics of the magnetic and structural α-ε phase transition in iron

Physical review letters, 2004-12, Vol.93 (25), p.255503.1-25503.4, Article 255503

2004

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(37)
Reviews
(3)

Sprache

Englisch
(29)
Französisch
(11)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Thalidomide Radiosensitizes Tumors through Early Changes in the Tumor Microenvironment

Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331

68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743)

PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers

749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032

ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

A randomized, open-label, phase 3 study of nivolumab in combination with ipilimumab vs extreme regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as first-line therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-CheckMate 651

LBA1_PRNivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Double-blind, two-arm, phase 2 study of nivolumab (nivo) in combination with ipilimumab (ipi) versus nivo and ipi-placebo (PBO) as first-line (1L) therapy in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)—CheckMate 714

LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331

Botulinum toxin potentiates cancer radiotherapy and chemotherapy

Brivanib (B) in Advanced Ovarian Cancer (OC): Subset Results of a Phase 2 Randomized Discontinuation Trial (RDT)

Optimal assessment of treatment benefit with targeted agents for hepatocellular carcinoma (HCC): An analysis of brivanib phase II data

Free Radicals in Licorice-Flavored Sweets Can Be Detected Noninvasively Using Low Frequency Electron Paramagnetic Resonance after Oral Administration to Mice

Epsilon iron as a spin-smectic state

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Regard croisé sur les jardins partagés et les Urbane Gemeinschaftsgärten

Laser-induced breakdown spectroscopy of copper with a 2 μm thulium fiber laser

Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial

Are Nutritional Guidelines Followed in the Pediatric Intensive Care Unit?

Pollution et risque alimentaire dans les jardins partagés franciliens

Les 20 printemps des jardins partagés français. Bilan et perspectives

Dynamics of the magnetic and structural α-ε phase transition in iron

Aktive Filter

Suchergebnisse filtern